| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |